Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
Clinical trial NCT03501368 · COMPLETED
Trial details
- NCT number
- NCT03501368
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2022-10-28
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.